Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$370,471,625
+$51,452,493 QoQ
Shares Held
1,458,722
+11.8% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#127
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. JNJ ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,471,625 | 1,458,722 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $319,019,132 | 1,305,102 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $324,692,959 | 1,568,944 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $328,911,715 | 1,773,874 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $230,684,117 | 1,510,207 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $243,779,492 | 1,469,968 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $216,975,842 | 1,500,317 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $252,118,684 | 1,555,712 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $238,951,573 | 1,634,863 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $196,210,174 | 1,240,345 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $142,483,868 | 909,046 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $146,470,258 | 940,419 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $211,856,991 | 1,279,948 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $182,083,770 | 1,174,734 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $214,195,188 | 1,212,540 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $235,264,862 | 1,440,162 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $242,943,912 | 1,368,621 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $258,023,837 | 1,455,870 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $242,250,514 | 1,416,090 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $221,745,474 | 1,373,037 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $221,514,839 | 1,344,633 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $216,767,622 | 1,318,939 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $227,625,302 | 1,446,342 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $225,057,278 | 1,511,669 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $213,763,645 | 1,520,043 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $200,699,840 | 1,530,541 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||